Immune dysfunction following COVID-19, especially in severe patients

Area of Science:

• Immunology
• Infectious Diseases
• Clinical Medicine

Background:

• Coronavirus disease 2019 (COVID-19) has caused a global pandemic with severe cases progressing rapidly.
• Understanding clinical features and risk factors is crucial for managing severe COVID-19 outcomes.

Purpose of the Study:

• To investigate the clinical characteristics of COVID-19 patients.
• To identify risk factors predicting severe disease progression.

Main Methods:

• Retrospective analysis of 79 confirmed COVID-19 patients (48 severe, 31 mild) and 37 healthy controls.
• Assessed immune cell counts (T, B, NK cells), inflammatory cytokines, white blood cell counts, neutrophil counts, and D-dimer levels.
• Utilized multivariate logistic regression, CT scores, clinical pulmonary infection score (CPIS), and ROC curve analysis.

Main Results:

• COVID-19 patients exhibited immune dysregulation, including decreased lymphocytes and increased inflammatory cytokines.
• Severe cases showed higher white blood cell counts, neutrophil counts, and D-dimer levels.
• Lower CD4+ T cell counts, elevated neutrophil-to-lymphocyte ratio (NLR), and higher D-dimer were significant risk factors for severity. CT score and CPIS correlated with disease severity.

Conclusions:

• Immune dysfunction is critical in COVID-19 progression.
• CD4+ cell count, NLR, and D-dimer are important predictors of severe COVID-19.
• Early monitoring of blood counts, immune subsets, coagulation, CT, and CPIS is recommended for identifying severe cases.